Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
27,578,755
-
Share change
-
+14,837,286
-
Total reported value
-
$3,195,693
-
Put/Call ratio
-
7.5%
-
Price per share
-
$0.12
-
Number of holders
-
44
-
Value change
-
+$1,705,942
-
Number of buys
-
14
-
Number of sells
-
12
Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q1 2023
As of 31 Mar 2023,
ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,578,755 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, CITADEL ADVISORS LLC, Tower Research Capital LLC (TRC), NORTHERN TRUST CORP, HRT FINANCIAL LP, and UBS Group AG.
This page lists
44
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.